Dr. Stein is a clinical psychologist, researcher, Professor, and Director of the ADHD Clinical Research Program. He has specialized in ADHD for more than 25 years. Dr. Stein has written more than 100 articles, co-edited the text book Attention Deficits and Hyperactivity in Children and Adults (Marcel Dekker, 2000), and has participated in numerous clinical tials of ADHD medications. His reserach has emphasized diagnosis of ADHD, genetics, thyroid, and psychopharmacology. Current research is on pharmacogenetics, dose response effects of medication, predicting response to methylphenidate and atomoxetine, and sleep problems.

For more information on the HALP Clinic please click here

Resources:

• American Psychological Association www.apa.org
• Attention Deficit Informatin Network www.addinfonetwork.org
• Children and Adults with Attention-Deficit/Hyperactivity Disorder (CHADD) http://www.chad.org
• Learning Disabilities Association of America (LDA) www.ldaamerica.org
• National Attention Deficit Disorder Association (ADDA) www.add.org
• National Dissemination Center for Children with Disabilities (NICHCY) www.nichcy.org
• Substance Abuse and Mental Health Services Administration (SAMHSA) National Mental Health Information Center: Center for Mental Health Services (CMHS) www.mentalhealth.org

Representative Publications

Stein, M.A., Blondis, T.A., Schnitzler, E.R., O'Brien, T., Fishkin, J., Blackwell, B, Szumowski, E., & Roizen, N. (1996). Methylphenidate dosing: Twice daily versus three times daily. Pediatric s ,98,748-756.

Stein, M.A., Krasowski, M., Leventhal, B.L., Phillips, W., & Bender, B.G (1996). Behavioral and cognitive effects of methylxanthines: A meta-analysis of theophylline and caffeine. Archives of Pediatric and Adolescent Medicine , 150, 284-288.

Cook, E.H., Stein, M.A., Krasowski, M.D., Cox, N.J., Olkon, D.M., Kieffer,J.E., & Leventhal, B.L. (1995) Association of Attention-Deficit Disorder and the Dopamine Transporter Gene. American Journal of Human Genetics, 56, 993-998.

Stein, M.A. (1999) Unraveling sleep problems in treated and untreated children with ADHD. Journal of Child and Adolescent Psychopharmacology , 9,157-158

Accardo P., Blondis, T., Whitman,B. & Stein, M. (1999) Attention Deficits and Hyperactivity in Children and Adults (2nd Ed), Marcel Dekker: New York , 760pp.

Stein, M.A., Mendelsohn, J., Obermeyer,W.H., & Benca, R. Sleep and Behavior Problems in School-Age Children. Pediatric s (electronic version), 2001.

Stein, M.A. & Weiss, R.E. Thyroid Function Tests and Neurocognitive Functioning in Children Referred for ADHD. Psychoneuroendocrinology (2003), 28,3,304-16.

Stein, M.A., Sarampote, C.S., Waldman,I.D., Robb, A.S., Conlon,C., Pearl, P.L., Black,D., Seymour, K & Newcorn,J.H. (2003) A Dose-Response Study of OROS Methylphenidate in Children with Attention Deficit Hyperactivity Disorder. Pediatrics , 112; e404-413.

Stein, M.A., Waldman, ID., Sarampote C.S., Seymour, K, Robb A., Kim, S.J., & Cook, E.H. (2005) Dopamine Transporter Genotype and Methylphenidate Dose-Response in Children with ADHD. Neuropsychopharmacology .30, 1374-1382.

Wilens T, McBurnett K, Stein M, Lerner M, Spencer T, Wolraich M, ADHD treatment with once-daily OROS methylphenidate: Final results from a long term open label study. Journal of the American Academy of Child and Adolescent Psychiatry (2005), 44, (10), 1015-1023